NASDAQ:CLOV

Clover Health Investments Stock News

Healthcare > Medical - Healthcare Plans

Buy CLOV

*Your capital is at risk

$4.27

-0.0600 (-1.39%)

At Close: Aug 04, 2026

Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller

08:30am, Thursday, 17'th Jul 2025

WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyon

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC's iCare+ Network

08:30am, Wednesday, 09'th Jul 2025

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality ca

Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025

08:30am, Tuesday, 08'th Jul 2025

WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its f

Clover Health Set to Join Russell 3000® Index

08:30am, Monday, 30'th Jun 2025

WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effec

All You Need to Know About Clover Health Investments (CLOV) Rating Upgrade to Strong Buy

01:05pm, Monday, 12'th May 2025

Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026

08:00am, Sunday, 11'th May 2025

Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenu

CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y

01:30pm, Wednesday, 07'th May 2025

Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.

Clover Health Investments, Corp. (CLOV) Q1 2025 Earnings Call Transcript

08:34pm, Tuesday, 06'th May 2025

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Pete

Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates

07:00pm, Tuesday, 06'th May 2025

Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.05 per share

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance

04:05pm, Tuesday, 06'th May 2025

First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line

Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

12:10pm, Monday, 05'th May 2025

MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

04:30pm, Thursday, 01'st May 2025

New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lo

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by